title: Comparative effects of hydroxocobalamin and cyanocobalamin on plasma homocysteine concentrations in end-stage renal disease.
abstract: End-stage renal disease (ESRD) is associated with marked hyperhomocysteinemia which is only partially corrected by folic acid and pyridoxine supplementation. We and others have reported that various forms of parenteral cobalamin reduce plasma total homocysteine (tHcy) concentrations of patients with ESRD substantially below the lowest levels attainable with folic acid. We here report a 16-week randomized controlled crossover trial which directly compared the Hcy-lowering effect of intravenous hydroxocobalamin (HC) with that of cyanocobalamin (CC). Folic acid- and vitamin B12-replete maintenance hemodialysis patients were randomly assigned to receive either 1 mg intravenous HC weekly for 8 weeks followed by CC for a further 8 weeks, or CC for 8 weeks followed by HC for 8 weeks. Hydroxocobalamin increased serum cobalamin concentrations 40-fold, whereas CC increased them only 10-fold, but both treatments reduced plasma tHcy concentrations similarly by 33% (P < .001). Crossover to the alternate form of the vitamin greatly affected the serum cobalamin concentration but was without further effect on the plasma tHcy concentration. These results confirm that weekly cobalamin injections lower plasma tHcy concentrations of hemodialysis patients well below the level attainable with folic acid. Hydroxocobalamin and CC are equipotent despite producing very different serum cobalamin concentrations.
authors.affiliation: Lady Davis Institute for Medical Research, Sir Mortimer B Davis-Jewish General Hospital, Montreal, Quebec, Canada H3T 1E2. l.hoffer@mcgill.ca
authors.forename: L John
authors.initials: LJ
authors.lastname: Hoffer
authors.forename: Orchidee
authors.initials: O
authors.lastname: Djahangirian
authors.forename: Paul E
authors.initials: PE
authors.lastname: Bourgouin
authors.forename: Johana
authors.initials: J
authors.lastname: Eid
authors.forename: Farhad
authors.initials: F
authors.lastname: Saboohi
mesh_terms: D018592:Cross-Over Studies; D005260:Female; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D006879:Hydroxocobalamin / Q000494:pharmacology*; D007676:Kidney Failure, Chronic / Q000097:blood*; D008297:Male; D014805:Vitamin B 12 / Q000494:pharmacology*
chemical_list: D006710:Homocysteine; D014805:Vitamin B 12; D006879:Hydroxocobalamin